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Abstract
Objective—We sought to quantify absorption of triclosan, a potential endocrine disruptor, in 
healthcare workers with occupational exposure to soap containing this chemical.
Methods—A cross-sectional convenience sample of two groups of 38 healthcare workers at 
separate inpatient medical centers: Hospital One uses 0.3% triclosan soap in all patient care areas; 
Hospital Two does not use triclosan-containing products. Additional exposure to triclosan-
containing personal care products was assessed through a structured questionnaire. Urine triclosan 
was quantified and the occupational contribution estimated through regression modeling.
Results—Occupational exposure accounted for an incremental triclosan burden of 206 ng/mL 
(p=0.02), while triclosan-containing toothpaste use was associated with 146 ng/mL higher levels 
(p<0.001).
Conclusions—Use of triclosan-containing antibacterial soaps in healthcare settings represents a 
substantial and potentially biologically relevant source occupational triclosan exposure.
Introduction
Triclosan is a synthetic, chemical, antibacterial agent found in many commercially available 
products labeled “antibacterial,” including personal care products such as soaps, toothpaste, 
cosmetics, and acne creams; it is also present in other consumer products.1,2 The majority of 
liquid soaps sold in the United States contain triclosan.3 Occupational sources represent a 
potentially important exposure scenario because some, albeit not all, healthcare institutions 
commonly use triclosan-containing antibacterial soaps and because frequent handwashing 
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among healthcare workers in such environments (range 0.7-30 times per hour)4 is likely to 
facilitate triclosan exposure.
A growing body of scientific research calls into question the safety of triclosan. For 
example, in vivo and in vitro studies have shown endocrine effects such as thyroid hormone 
disruption 5-7 and perturbation of sex hormone homeostasis. 8-14 In addition, triclosan 
exposure may impair muscle function in animal models15 and also has been associated with 
hay fever or allergies in humans. 16-17 Despite these potential effects, human toxicity from 
triclosan has not been established or excluded and, thus, this chemical has been tentatively 
categorized as having “insufficient evidence to classify as safe or effective” (Category 
IIISE) by the U.S. Food and Drug Administration (FDA).18 Addressing this knowledge gap, 
the U.S. FDA recently proposed to include triclosan among a group of antibacterial 
products, requiring additional safety data and demonstration of clinical benefit over the use 
of plain soap. 18
Triclosan is absorbed following trans-dermal or oral exposure. Quantification of triclosan in 
urine represents a key biomonitoring instrument for such absorption because triclosan (as 
free and conjugated metabolites) is excreted primarily in urine, with a half-life of about 11 
hours in humans. 19, 20 In 2003-04, a U.S. population-based sample (n=2517) in the National 
Health and Nutrition Examination Survey (NHANES) showed that 75% had detectable urine 
triclosan levels. 21 Limited (n=91) but more recent biomonitoring data from California 
found that triclosan was detectable in 95% of the samples tested. 22
Given the potential adverse human health effects of triclosan, better characterization of 
exposure risks is warranted. We hypothesized that biomonitoring would establish that the 
burden of triclosan in healthcare workers is indeed higher due to occupational exposure and 
that, among such persons, personal care product would superimpose even greater exposure. 
To test this, we compared urine triclosan levels among physicians and nurses at two 
hospitals in close geographic proximity: one that uses triclosan-containing hand washing 
soap and one that does not.
Methods
Design and Subjects
We carried out a cross-sectional study in a convenience sample of physicians and nurses at 
two hospitals. Hospital One uses a 0.3% triclosan-based soap in all patient care areas and 
restrooms (staff and public). Hospital Two uses plain soap and water, having previously 
phased-out triclosan-containing soaps. Both hospital sites also have a water-free alcohol 
based hand rub for hand hygiene (a product that does not contain triclosan). To be eligible 
for study inclusion, participants were required to be a physician (MD or DO) or nurse (RN) 
employed on a full-time basis at their hospital site (defined as regularly working ≥36 hours 
per week), and to have worked at least 8 of the 48 hours prior to study recruitment. Potential 
subjects also were required to complete a brief questionnaire (detailed below). Those 
otherwise eligible were excluded if they failed to provide a urine sample for triclosan 
analysis. Four otherwise eligible participants who did not provide a satisfactory urine sample 
were thus excluded.
MacIsaac et al. Page 2













Institutional Review Board approval was obtained from each of the two hospital study sites. 
Recruitment ran form March through August 2012. Questionnaire completion and spot urine 
sample collection occurred immediately following a brief presentation about the project at 
various staff meetings onsite (these included educational events as well as standard staff 
meetings). Following each presentation, healthcare workers were invited to participate. 
Altogether 15 separate recruitment presentations were made at times ranging from 6AM to 
7PM.
Exposure Questionnaire
We developed a brief survey questionnaire using an iterative process of review within the 
study team. Items on the timing of recent exposure took into account a triclosan half-life of 
approximately 11-hours; work exposure assessed the anticipated primary factor driving hand 
washing (patients directly cared for); and exposure to triclosan-containing personal product 
included toothpaste given the efficiency of buccal absorption23 (specifically eliciting use of 
the only brand of triclosan-containing toothpaste on the US market, Colgate Total ®). In 
addition, since four out of five liquid soaps contain triclosan3, home antibacterial soap use 
was also included, along with acne creams given their triclosan content.24 The survey, 
although intentionally brief, did include items that also estimated potential exposure to 
phthalates to inform a future research project. The survey instrument exclusive of the 
phthalate items is available as an online supplement
Laboratory Methods
The spot urine sample was collected in phthalate- and triclosan-free urine containers. 
Immediately following collection, urine samples (room temperature) were transported to the 
laboratory within one hour. Analysis of free and total triclosan in urine was carried out by 
liquid chromatography-tandem mass spectrometry. The limit of detection (LOD) for both 
analytes is 0.05 μg/L. Quantitation of each analyte was done by isotope dilution method 
using a 10-point calibration curve. Each analyte has a limit of quantitation (LOQ) of 0.1 
μg/L. For details of the laboratory methods see the online supplement.
Data Analysis
The mean and standard deviation for age and urinary creatinine were calculated for each 
hospital site stratum and for the entire cohort. We tested differences using the t-test for the 
age, the Wilcoxon test for the number of hours worked in the 48-hr period prior to 
participation, and the creatinine. Differences in categorical variables were tested using the 
chi-square test. Descriptive statistics for triclosan levels (free, conjugated and total) were 
calculated for each hospital site and for the entire study sample for all participants and for 
participants stratified by TCT use (since TCT was a major potential source of triclosan 
exposure, independent of hospital exposure). The overall differences in triclosan levels by 
hospital site and by TCT use analyzed together were tested by ANOVA; pairwise 
comparisons used the Wilxocon rank sum for median values and the t-test for mean values. 
To facilitate comparison to national data (NHANES) 21, the geometric mean urinary 
triclosan levels adjusted for creatinine were calculated for the exposed and unexposed 
groups.
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We performed a multiple linear regression analysis among all study participants to analyze 
the combined effects of TCT use and hospital exposure, adjusting for the covariates of age 
and urinary creatinine. To further assess the role of other cofactors and to take into account 
the differing mix by site of profession and sex, we re-estimated the linear regression models 
stratified by site and further including in addition to the variables in the previous models 
profession, sex (male), number of workplace hand washings in past 24 hours, time worked 
over the past 48 hours, and personal use of antibacterial soaps.
Results
We studied 76 participants, 38 from each hospital site (Table 1). The mean age was 35±9.6 
years, the majority was female, and the study population was divided fairly equally among 
physicians and nurses. There were, however, significant demographic differences between 
those studied at the two hospitals. Participants from Hospital One (which used triclosan-
containing disinfectant soap) were 7.5 years older on average (p<0.001) and included fewer 
physicians (13% vs. 84%, p<001). Although the Hospital One group also had a higher 
proportion of females, this difference was not statistically significant. The nurses compared 
to physicians were less likely to be male 4 (10.3%) of 39 compared to 15 (40.5%) of 37 
(p<0.01).
Among the exposure cofactors of interest (Table 1), there were no statistically significant 
differences by hospital site, although the use of TCT was more prevalent among participants 
at Hospital Two. The median number of hours worked at Hospital One in the previous 48 
hours (median=13) indicated sufficient time for occupational exposure at that site, as did the 
frequency of hand washing at work (median=8, range 0-40). Urinary creatinine, a marker of 
specimen concentration that might confound triclosan quantification, was similar in the two 
groups.
Table 2 shows observed values for urinary triclosan by hospital site for free, conjugated, and 
total triclosan, respectively. Because the use of TCT was a potent potential source of 
triclosan exposure independent of hospital site, the data were further stratified by that factor. 
Overall, values of free triclosan were more than an order of magnitude lower than 
conjugated triclosan among both TCT and non-TCT users. Because of the dominance of 
conjugated relative to free values, total triclosan levels were quite similar to the conjugated 
levels. Of the six highest observed total urinary triclosan values (range 416 to 505 ng/mL), 
three were from Hospital One (one of these had co-exposure to TCT) and three were from 
Hospital Two (all TCT users) (data not in Table).
Among non-TCT uses, the urinary concentrations of total (non-conjugated and conjugated 
combined) triclosan were significantly higher at Hospital One compared to Hospital Two 
(median values 68.5 vs. 8.6 ng/mL; p=0.02). In contrast, among TCT users the 
concentrations were higher but quite similar by hospital (255 vs. 258 ng/mL; p>0.8). Among 
the two groups of TCT and non-TCT users combined, Hospital One manifested higher levels 
than Hospital Two, but this difference was not statistically significant. Free triclosan levels 
did not differ by hospital for either TCT stratum. All comparisons in Table 2 were tested 
non-parametrically; parametric testing, however, did not yield findings that were 
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substantively different (data not shown). The geometric mean total triclosan level was 92.92 
ng/mL for Hospital One and 36.65 ng/mL for Hospital Two. The overall mean free triclosan/
urinary creatinine ratio (microgram per mg) was 0.04±0.08 (median 0.011); the mean 
conjugated value was 2.58±5.0 (median 0.85).
In order to analyze the combined effects of TCT use and potential exposure to triclosan 
through hand soap in Hospital One, we tested models including both of these two risk 
factors, also including as covariates age and urinary creatinine. The parameter estimates for 
TCT use and site of hospital employment are shown in Table 3. Taking into account 
employment site, TCT use was associated with 142 and 146 ng/mL urine higher values for 
conjugated and total triclosan, respectively (p<0.001). Working in Hospital One was 
associated with a urine conjugated triclosan level of 205 ng/mL (p=0.02) and a very similar 
estimate for total triclosan (206; p=0.02). Use of TCT was associated with free triclosan 
(p=0.051); hospital employment site was not statistically associated with free triclosan in the 
multivariate analysis. Because of the inter-correlations among hospital site, profession 
(nurse vs. physician) and sex, we sought to examine further TCT use and occupational 
exposure as predictors of urinary triclosan stratified by hospital and taking into account 
other cofactors that might mediate exposure or modify the delivered dose (Table 4). There 
was no consistent pattern of association with the additional factors tested. The point estimate 
for the association of TCT with urinary free and conjugated triclosan was lower in Hospital 
One and higher in Hospital Two (and statistically significant for conjugated triclosan in the 
latter). Being a nurse in Hospital One was notable for an association with increased 
conjugated triclosan (p=0.09), while male sex in Hospital One was associated with a higher 
free triclosan (p=0.052) level. Inclusion of all of the additional covariates in these analyses 
only marginally increased the explanatory power of the model as compared to the restricted 
model limited to TCT use, hospital site, age and creatinine (as shown in Table 3): for free 
triclosan, model R2 = 0.31 (vs. 0.24) and conjugated triclosan R2= 0.62 (vs. 0.60). 
Moreover, the estimated intercepts in these models did not differ statistically from zero, that 
is, we could not exclude as a chance observation a detectable level of triclosan that would be 
present without any of the modeled risk factors.
Discussion
To our knowledge this is the first peer-reviewed biomonitoring study to measure triclosan 
levels among healthcare workers. The study underscores hospital exposure and use of TCT 
as important sources of exposure to triclosan. Among non-TCT users, there were 
significantly higher conjugated and total triclosan levels in those who worked in the hospital 
that used triclosan-containing soap in all patient care areas. In the hospital that did not use 
triclosan, TCT was the dominant contributor to the observed levels and, in the stratum of 
TCT users, obscured the differences between the two hospitals. Multivariate analysis, taking 
into account both TCT use and hospital, however, made it clear that both factors were 
independent predictors of the triclosan burden and that the occupational factor, overall, was 
associated with the largest estimated effect.
It is not surprising that TCT use correlated with higher urinary triclosan levels. Other studies 
have showed that buccal absorption of triclosan is high. For example, Allymr and 
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colleagues 23 reported that after brushing with 0.3% TCT for 14 days, subjects had triclosan 
blood levels that were increased by several orders of magnitude (from 0.009-0.81ng/g pre-
exposure to 26-296ng/g after exposure; p=0.003). Lin et al measured blood levels of 
triclosan 4 hours after rinsing with 0.03% triclosan mouthwash and found that 7.5% of the 
total administered dose was absorbed. 25
Of interest, the free triclosan levels did not differ by hospital for any stratum. This may be 
due to a conjugation that occurs locally by skin cells, consistent with findings in a rat 
model. 26 While conjugation also occurs in the liver, it is possible that dermal absorption 
does not contribute significantly to levels of free triclosan, thus explaining the pattern we 
observed.
As stated above, the geometric mean total urine triclosan was 92.92 ng/mL for the exposed 
and 36.65 ng/mL for the unexposed hospital. By comparison, a representative sample of the 
general U.S. population for adults (20 yrs. and older) in NHANES for the years 2009-10 
observed a geometric mean total urine triclosan level of 15.5 ng/mL (95% CI 12.9-18.5). 27 
Based on those data, Hospital One falls between the 75th and 90th percentile values of the 
NHANES data (61.8 and 262 ng/mL respectively), whereas Hospital Two falls between the 
50th and 75th percentile (11.1 and 61.8 ng/mL respectively). Calafat et al (2008) found that 
in NHANES data, higher levels were seen during the third decade of life and among people 
with the highest household income, and that levels did not vary by ethnicity/race or sex. 21 
Thus, the higher overall geometric mean levels we observed may be explained, at least 
partially, by higher socioeconomic status and older age.
Our study has several important limitations. A major limitation of our study design is its 
reliance on a cross-sectional, convenience sample of participants rather than employing an 
alternative design, such as a stratified random sample of the entire working populations of 
the two hospitals studied or, even more ideally, a cross-over intervention trial in which 
triclosan-containing soap was allowed, removed, and then re-added to the work 
environment. It is possible, for example, that those with the greatest triclosan exposure at 
work would be more concerned about their triclosan exposure levels and thus be more likely 
to participate, although this might also occur with randomly selected potential participants. 
Nonetheless, although this phenomenon might lead to an overestimate of exposure levels, it 
would not be likely to account for all of the hospital site-related effect that was observed. In 
addition, the sample size is small, especially in regard to the stratified analyses that might 
analyze possible interactions among risk factors. Because no pre-existing validated 
questionnaire assessing exposure to triclosan among hospital workers was available, we 
developed de novo the survey instrument used in this investigation. Moreover, the survey 
was constrained by brevity given the demanding work schedules of potential study 
participants. The relationship between the relevant exposure items and measured triclosan, 
however, supports the content validity of the survey. Our study relied on participant's recall 
of specific types of products used, which may have led to exposure misclassification. At the 
triclosan-exposed hospital, given two principal options for hand hygiene (water-free hand 
rub and the triclosan-containing soap), there were varying levels of exposure to triclosan. 
This was reflected in the wide range of reported hand washings with triclosan-containing 
soap while working in Hospital One. In addition, due to feasibility constraints we did not 
MacIsaac et al. Page 6













measure serum triclosan levels, which would have required a phlebotomy protocol (and 
would also have been likely to hinder participation).
There are hundreds of triclosan-containing products the use of which, for the sake of brevity, 
were not included in the questionnaire and participants may have had sources of triclosan 
exposure that were not accounted for. This was not likely to have made a large contribution, 
however, given that the intercept of the model estimates was not statistically different than 
zero, although larger sample size would have provided greater study power in that regard. 
We were also limited by our inability to set a fixed recruitment schedule that might have 
reduced the variability in time from last exposure until urine sampling. For example, 
because the half-life of triclosan is less than 12 hours, those with work exposure on a 
previous shift but not yet exposed on the day of measurement would tend to have lower 
levels of triclosan detected than might have been measured sooner post-shift; similarly, 
exposure to TCT that occurred in the morning before work with sampling in the late 
afternoon might have had lower levels than had that person been sampled earlier. 
Nonetheless, although this effect to the extent present would have led to a lower estimate of 
effect, it should not have acted in a systematic way to account for the associations that we 
did observe.
Despite these limitations, our analysis has identified a role for occupational exposure in our 
participants' triclosan burden. Because biostatical modeling based on a relatively small 
convenience sample is constrained by wide confidence intervals, however, further bio-
monitoring studies with a larger sample size of randomly selected individuals would be 
necessary to confirm these results. This is all the more relevant because the effects of long-
term, low level human triclosan exposure are unknown, but in vivo and in vitro experimental 
data have raised serious questions regarding potential adverse endocrine and other effects. 
Moreover, at least one such analysis focusing on skeletal and cardiac muscle impairment in 
mice studied triclosan concentrations in a range that has been reported in humans. 15 These 
endocrine disrupting and myotoxic effects seen have yet to be evaluated in human studies, 
and therefore health effects in humans at current exposure levels remain unknown. Large 
scale human studies at current exposure levels in vulnerable subpopulations such as the fetus 
or developing child have not been done, and are unlikely to be performed given feasibility 
constraints. Of note as well, beyond direct toxicity there are also human and wider 
environmental concerns associated with triclosan. For example, there is evidence to suggest 
that the use of triclosan may contribute to antibiotic resistance among selected pathogenic 
microbes. 28 Further, triclosan is biopersistent in the environment. The widespread, routine 
use of triclosan is called further into question in light of lack of proven antimicrobial 
efficacy for this chemical. A review of both microbial counts and infectious diseases 
prevention found that, that at typical concentrations, triclosan-containing soaps have no 
more efficacy than ordinary soap and water. 29
Until the clinical benefit weighted against any potential human adverse health and wider 
negative environmental effects of triclosan have been delineated more fully, it may be best 
to take an precautionary approach as elucidated by Kriebel et al: “when an activity raises 
threats of harm to human health or the environment, precautionary measures should be taken 
even if some cause and effect relationships are not fully established scientifically”. 30
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Triclosan is an antibacterial added to many products, including disinfectant soaps used in 
many health care facilities. Triclosan is a potential human endocrine disruptor with 
possible adverse health effects and wide population exposure. This study quantifies the 
contribution of occupational exposure among health care workers to the human triclosan 
burden.
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Table 1
Characteristics of Participants by Hospital of Employment among 76 Physicians and 
Nurses Studied
Subject Characteristics All (n=76) Hospital One (n=38) Hospital Two (n=38) P value
Demographics
 Age in years, mean±SD 35.1±9.6 38.8 ± 11.4 31.3 ± 6.2 <0.001
 Female Sex, n (%) 57 (75%) 31 (82%) 26 (68%) 0.15
 Profession, n (%) <0.001
  Physician 37 (49%) 5 (13%) 32 (84%)
  Nurse 39 (51%) 33 (87%) 6 (16%)
Exposure Co-factors
 Hours worked in last 48 hours, median (IQR) 16 (11) 13 (12) 19 (9.8) 0.19
 Work hand washing in last 24 hours, median (IQR) 8 (8) 9 (14) 8 (7) 0.19
 Use of TCT, n (%) 29 (39%) 11 (31%) 18 (47%) 0.15
 Use of anti-bacterial soap outside of work, n (%) 51 (69%) 25 (68%) 26 (70%) 0.69
 Urinary Cr, median (IQR) 74.0 (92.5) 61.8 (85.3) 85.0 (108.1) 0.23
Hospital One uses triclosan-containing soaps, Hospital Two does not (see Methods)
IQR= Interquartile Range; TCT= Triclosan-containing toothpaste
P value for comparison between hospital sites by chi square, t-test (age), or Wilcoxon (hours, creatinine)
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Table 3
Hospital Worksite and Triclosan-containing Toothpaste as Predictors of Urinary 
Triclosan in Multiple Linear Regression Analysis
Model tested Model R2 Beta coefficient ± SE ng/mL Urine P value
Free TRI 0.242
 TCT use 3.82 ± 1.93 0.051
 Employed in Hospital 1 0.77 ± 4.93 0.88
Conjugated TRI 0.595
 TCT use 142.25 ± 32.61 <0.001
 Employed in Hospital 1 204.90 ± 83.45 0.017
Total TRI 0.596
 TCT use 146.07 ± 33.51 <0.001
 Employed in Hospital 1 205.66 ± 88.77 0.019
TRI =Triclosan; TCT=Triclosan Containing Toothpaste
All models also include age and urinary creatinine.
Age was not statistically significant in any model; urinary creatinine p =0.01 for free TRI only (parameter estimates not shown).
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Table 4
Multivariate Linear Regression: Urinary Triclosan Stratified by Hospital
Hospital One (Using Triclosan-Containing Soap)




Male Sex 6.4±4.2 0.05




Male Sex 77.2±70.6 0.28
Hand Washing Frequency 0.5±2.7 0.86




Male Sex 1.6±3.8 0.68




Male Sex -3.6±52.9 0.95
Hand Washing Frequency 0.40±3.9 0.92
TRI = Triclosan; TCT= Triclosan Containing Toothpaste
Models also include the additional variables of age, urinary creatinine, hours worked in the previous 48, and the use of antibacterial soap (all 
p>0.10 in all models tested).
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